Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

Status: COMPLETED
Phase: NA

A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)

Status: TERMINATED
Phase: PHASE2/PHASE3

A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

Status: COMPLETED
Phase: PHASE1

Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients

Status: RECRUITING
Phase: N/A

Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)

Status: COMPLETED
Phase: PHASE1

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Status: RECRUITING
Phase: PHASE2

A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)

Status: COMPLETED
Phase: PHASE1

Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

Status: NOT_YET_RECRUITING
Phase: PHASE4

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

Status: RECRUITING
Phase: PHASE2

Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence

Status: NOT_YET_RECRUITING
Phase: N/A

Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Status: RECRUITING
Phase: PHASE1

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE1

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

Status: TERMINATED
Phase: N/A

Muscle Relaxation for Pediatric Adenotonsillectomy

Status: COMPLETED
Phase: PHASE4

Parkinson's Disease Progression Study

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2